TruSight Oncology 500 (TSO500) is a high performance gene panel, for use with the NextSeq Instrument, that enables research laboratories to evaluate, in a single assay, the most clinically relevant tumor DNA and RNA biomarkers, across multiple cancer types.
With content aligned to key clinical guidelines, and inclusion of the highly relevant immunotherapy biomarkers of tumor mutational burden (TMB) and microsatellite instability (MSI), TSO500 provides limitless possibilities to molecular pathologists!
Product information
For Research Use Only. Not for use in diagnostic procedures.
Company Info:
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe. For further details please visit www.illumina.com.
Contact Information:
Illumina Cambridge Ltd, Granta Park, Great Abington, Cambridge CB21 6GP, United Kingdom
Telephone: + 44 (0) 1 223 824 800
Contact request: https://emea.illumina.com/forms/contact_request.html
QB# 6691
